Target intelligence / Profile preview

Rhodopsin promoter (RHO promoter) (RHO promoter)

Target
RHO promoter
Molecular classification
Other, DNA regulatory element
01

Overview

The Rhodopsin (RHO) promoter is a critical regulatory DNA sequence located upstream of the RHO gene, primarily responsible for directing the high-level, rod-specific expression of the rhodopsin protein in the retina (NIH, 2023). Rhodopsin is a specialized G protein-coupled receptor (GPCR) that initiates the phototransduction cascade, allowing for vision in dim light conditions (UniProt, 2024). Mutations within the RHO gene or its regulatory elements are a primary cause of Retinitis Pigmentosa (RP), particularly the autosomal dominant form (adRP), which leads to progressive rod cell death and eventual blindness (PubMed, 2021). In the field of precision medicine, the RHO promoter is targeted by experimental gene-editing tools like CRISPR-Cas9 and CRISPR interference (CRISPRi) to selectively silence mutant alleles or modulate gene dosage (Nature Communications, 2016). Furthermore, the promoter is frequently incorporated into viral vectors, such as Adeno-associated virus (AAV), to ensure that therapeutic transgenes are expressed exclusively within rod photoreceptors, minimizing off-target effects in other retinal layers (Molecular Therapy, 2020). Precise regulation of this promoter is vital, as both the absence of rhodopsin and its excessive accumulation can lead to photoreceptor degeneration and permanent vision loss (PubMed, 2018).

Other names
RHO gene promoterOpsin promoterRhodopsin regulatory elementRHO regulatory region
02

Mechanism of action

Targeted transcriptional modulation and gene editing to regulate the expression levels of the rhodopsin gene in rod photoreceptors.

03

Biological functions

Regulation of gene expressionVisual perceptionRod photoreceptor maintenanceOther
04

Disease associations

Neurodegenerative diseaseRetinitis pigmentosaAutosomal dominant retinitis pigmentosaCongenital stationary night blindnessOther
05

Safety considerations

Off-target genomic editingRhodopsin overexpression toxicityViral vector-induced inflammationSubretinal injection-related injury
06

Interacting drugs

CRISPR-Cas9 (experimental)

3 more in the full profile.

07

Biomarkers

RHO mRNA levelsRhodopsin protein levelsElectroretinogram (ERG) amplitudesOuter nuclear layer (ONL) thickness

Beyond the preview

Go deeper on Rhodopsin promoter (RHO promoter) (RHO promoter).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rhodopsin promoter (RHO promoter) (RHO promoter).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call